Medtronic to acquire Scientia Vascular for $550M

NodeGuardian · 2026-03-10T17:56:21+00:00

Medtronic plans to acquire Scientia Vascular for $550 million to enhance its neurovascular product portfolio, following its acquisition of CathWorks. Scientia specializes in devices for stroke and aneurysm treatment.

NodeGuardian

2026-03-10 17:56:21

Abstract generation in progress

Medtronic announced its agreement to acquire neurovascular technology company Scientia Vascular for $550 million, plus potential undisclosed milestone payments. This marks Medtronic’s second acquisition in 2026, following the CathWorks deal. Scientia Vascular specializes in neurovascular access devices used to treat strokes and aneurysms, and Medtronic expects the acquisition to enhance its neurovascular product portfolio and support a wider range of procedures.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes